These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2477 related articles for article (PubMed ID: 29449511)

  • 1. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.
    Chen JS; Ma E; Harrington LB; Da Costa M; Tian X; Palefsky JM; Doudna JA
    Science; 2018 Apr; 360(6387):436-439. PubMed ID: 29449511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity.
    Stella S; Mesa P; Thomsen J; Paul B; Alcón P; Jensen SB; Saligram B; Moses ME; Hatzakis NS; Montoya G
    Cell; 2018 Dec; 175(7):1856-1871.e21. PubMed ID: 30503205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
    Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
    Murugan K; Seetharam AS; Severin AJ; Sashital DG
    J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High concentration of Cas12a effector tolerates more mismatches on ssDNA.
    Li H; Cui X; Sun L; Deng X; Liu S; Zou X; Li B; Wang C; Wang Y; Liu Y; Lu B; Cao B
    FASEB J; 2021 Jan; 35(1):e21153. PubMed ID: 33159392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bridge helix of Cas12a imparts selectivity in cis-DNA cleavage and regulates trans-DNA cleavage.
    Parameshwaran HP; Babu K; Tran C; Guan K; Allen A; Kathiresan V; Qin PZ; Rajan R
    FEBS Lett; 2021 Apr; 595(7):892-912. PubMed ID: 33523494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease.
    Curti LA; Pereyra-Bonnet F; Repizo GD; Fay JV; Salvatierra K; Blariza MJ; Ibañez-Alegre D; Rinflerch AR; Miretti M; Gimenez CA
    Emerg Microbes Infect; 2020 Dec; 9(1):1140-1148. PubMed ID: 32486913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved genome editing by an engineered CRISPR-Cas12a.
    Ma E; Chen K; Shi H; Stahl EC; Adler B; Trinidad M; Liu J; Zhou K; Ye J; Doudna JA
    Nucleic Acids Res; 2022 Dec; 50(22):12689-12701. PubMed ID: 36537251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12a targeting of ssDNA plays no detectable role in immunity.
    Marino ND; Pinilla-Redondo R; Bondy-Denomy J
    Nucleic Acids Res; 2022 Jun; 50(11):6414-6422. PubMed ID: 35670674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Making the cut(s): how Cas12a cleaves target and non-target DNA.
    Swarts DC
    Biochem Soc Trans; 2019 Oct; 47(5):1499-1510. PubMed ID: 31671185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mg
    Son H; Park J; Hwang I; Jung Y; Bae S; Lee S
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34853172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-Free and Universal CRISPR/Cas12a-Based Detection Platform for Nucleic Acid Biomarkers.
    Zhao R; Xiao Y; Tang Y; Lu B; Li B
    ACS Sens; 2024 Sep; 9(9):4803-4810. PubMed ID: 39283984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive and visual detection of SARS-CoV-2 using RPA-Cas12a one-step assay with ssDNA-modified crRNA.
    Zeng Q; Zhou M; Deng W; Gao Q; Li Z; Wu L; Liang D
    Anal Chim Acta; 2024 Jun; 1309():342693. PubMed ID: 38772660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endonuclease-Assisted PAM-free Recombinase Polymerase Amplification Coupling with CRISPR/Cas12a (E-PfRPA/Cas) for Sensitive Detection of DNA Methylation.
    Zhou S; Dong J; Deng L; Wang G; Yang M; Wang Y; Huo D; Hou C
    ACS Sens; 2022 Oct; 7(10):3032-3040. PubMed ID: 36214815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indiscriminate ssDNA cleavage activity of CRISPR-Cas12a induces no detectable off-target effects in mouse embryos.
    Wei Y; Zhou Y; Liu Y; Ying W; Lv R; Zhao Q; Zhou H; Zuo E; Sun Y; Yang H; Zhou C
    Protein Cell; 2021 Sep; 12(9):741-745. PubMed ID: 33797032
    [No Abstract]   [Full Text] [Related]  

  • 18. Conformational control of DNA target cleavage by CRISPR-Cas9.
    Sternberg SH; LaFrance B; Kaplan M; Doudna JA
    Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of logic gates to CRISPR/Cas12a system for rapid and sensitive detection of pathogenic bacterial genes.
    Peng L; Zhou J; Yin L; Man S; Ma L
    Anal Chim Acta; 2020 Aug; 1125():162-168. PubMed ID: 32674762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.
    Harrington LB; Burstein D; Chen JS; Paez-Espino D; Ma E; Witte IP; Cofsky JC; Kyrpides NC; Banfield JF; Doudna JA
    Science; 2018 Nov; 362(6416):839-842. PubMed ID: 30337455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.